A New Chapter for the RATIONAL-Platform: Recruitment Begins in Canada

We are delighted to announce the first participant recruitment in Canada on the RATIONAL-Platform in August, marking the official commencement of the Canadian arm of the trial.

With Australia already open and actively recruiting, the initiation of recruitment in Canada represents an important milestone in expanding the trial internationally.

The RATIONAL-Platform aims to generate real-world evidence on immunoglobulin (Ig) versus antibiotic use in patients with blood cancers and hypogammaglobulinemia, with a focus on infection prevention and informing evidence-based clinical practice. This milestone reflects the strength of our international collaboration and the shared commitment of participating teams to address an important unmet clinical need.

Congratulations to our Canadian colleagues and collaborators on this achievement and thank you to everyone contributing to bringing this international initiative to life. We look forward to the next phase of recruitment and to generating meaningful real-world evidence together.